⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10757852 | 0.85 | — | — | |
| SCHEMBL27365834 | 0.83 | — | — | |
| SCHEMBL12862696 | 0.83 | — | — | |
| SCHEMBL19781764 | 0.81 | — | — | |
| SCHEMBL9880642 | 0.81 | — | — | |
| SCHEMBL17703506 | 0.81 | — | — | |
| SCHEMBL26780057 | 0.77 | GABRA1 (0.39) | — | |
| SCHEMBL17703503 | 0.75 | TSHR (0.37) | — | |
| SCHEMBL9311927 | 0.75 | KDM4E (0.50) | — | |
| SCHEMBL6627066 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109249151-B | Solder composition and electronic substrate | 株式会社田村制作所 | 2021-12-14 | — | — | CN | claimed |
| CN-112358439-A | Omeprazole process impurity and preparation method thereof | 成都百泉生物医药科技有限公司 | 2021-02-12 | — | — | CN | claimed |
| US-10906137-B2 | Solder composition and electronic board | TAMURA CORPORATION (JP) | 2021-02-02 | — | — | US | claimed |
| CN-121930166-A | Urea cyclization method for synthesizing 3, 5-dimethyl-4-hydroxypyridine and chlorohydroxypyridine | 华南农业大学 | 2026-04-28 | — | — | CN | disclosed |
| CN-121930166-A | Urea cyclization method for synthesizing 3, 5-dimethyl-4-hydroxypyridine and chlorohydroxypyridine | 华南农业大学 | 2026-04-28 | — | — | CN | disclosed |
| US-12054472-B2 | 1,2,4-triazine-4-amine derivatives | NXERA PHARMA UK LIMITED (GB) | 2024-08-06 | — | — | US | disclosed |
| US-20230021177-A1 | 1,2,4-TRIAZINE-4-AMINE DERIVATIVES | NXERA PHARMA UK LIMITED (GB) | 2023-01-19 | — | — | US | disclosed |
| CN-109249151-B | Solder composition and electronic substrate | 株式会社田村制作所 | 2021-12-14 | — | — | CN | disclosed |
| US-10988455-B2 | 1,2,4-triazine-4-amine derivatives | HEPTARES THERAPEUTICS LIMITED (GB) | 2021-04-27 | — | — | US | disclosed |
| CN-112358439-A | Omeprazole process impurity and preparation method thereof | 成都百泉生物医药科技有限公司 | 2021-02-12 | — | — | CN | disclosed |
| US-10906137-B2 | Solder composition and electronic board | TAMURA CORPORATION (JP) | 2021-02-02 | — | — | US | disclosed |
| WO-2011095625-A1 | 1,2,4-TRIAZINE-4-AMINE DERIVATIVES | HEPTARES THERAPEUTICS LIMITED (GB) | 2011-08-11 | — | — | WO | disclosed |
| US-7579469-B2 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2009-08-25 | — | — | US | disclosed |
| WO-2007084415-A2 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION (US) | 2007-07-26 | — | — | WO | disclosed |
| EP-1583745-A1 | 1-PROPANOL AND 1-PROPYLAMINE DERIVATIVES AND THEIR USE AS GLUCOCORTICOID LIGANDS | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2005-10-12 | — | — | EP | disclosed |
| US-20040162321-A1 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2004-08-19 | — | — | US | disclosed |
| WO-2004063163-A1 | 1-PROPANOL AND 1-PROPYLAMINE DERIVATIVES AND THEIR USE AS GLUCOCORTICOID LIGANDS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2004-07-29 | — | — | WO | disclosed |
| EP-0974602-B1 | Catalyst and process for hydrogenating olefinically unsaturated compound | JSR CORP (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-6291596-B1 | CONTACTING OLEFINICALLY UNSATURATED COMPOUND WITH HYDROGEN IN THE PRESENCE OF A HYDROGENATION CATALYST COMPRISING TITANIUM OR ZIRCONIUM OR HAFNIUM COMPOUND IN AN INERT, ORGANIC SOLVENT | JSR CORPORATION (JP) | 2001-09-18 | — | — | US | disclosed |
| EP-0974602-A1 | Catalyst and process for hydrogenating olefinically unsaturated compound | JSR Corporation (JP) | 2000-01-26 | — | — | EP | disclosed |